Dr. Yorio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6204 Balcones Dr
Austin, TX 78731Phone+1 512-427-9400Fax+1 512-342-2723
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2008 - 2011
- University of Texas Southwestern Medical SchoolClass of 2008
Certifications & Licensure
- TX State Medical License 2010 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 26 citationsInfluence of Medical Comorbidities on the Presentation and Outcomes of Stage I-III Non–Small-Cell Lung CancerDaniel H. Ahn, Nishi Mehta, Jeffrey T. Yorio, Yang Xie, Jingsheng Yan
Clinical Lung Cancer. 2013-11-01 - 26 citationsCombined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.Sara Bedrose, Kevin C. Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar
Journal for Immunotherapy of Cancer. 2020-07-01 - 1 citationsA Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B Goodman Jr
European Urology Oncology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: